• “Prospective evaluation of the sensitivity and specificity of cognitive tasks for diagnosis of the cerebellar cognitive affective syndrome.”
Cognitive Skills in Alzheimer’s and Parkinson’s Disease


Researchers at the Massachusetts General Hospital are looking for patients with mild to moderate Alzheimer’s and Parkinson’s disease to participate in a study of cognition


Researchers in the Department of Neurology at MGH are looking for patients with mild to moderate Alzheimer’s or Parkinson’s disease to take part in a study entitled “Prospective evaluation of the sensitivity and specificity of cognitive tasks for diagnosis of the cerebellar cognitive affective syndrome.”

Your participation will lead to the development of a brief clinical test battery to screen for the cerebellar cognitive and affective syndrome (CCAS).

Participants will receive full neurocognitive testing and will be compensated with $30 and free parking.


You may be eligible to participate in this study if you meet the following criteria:
• Are 18 years or older
• Have mild to moderate Alzheimer’s or Parkinson’s disease
• Have no other known neurological or psychiatric conditions
• Are able to come in for 1 visit lasting 3 hours, or 2 visits lasting 90 minutes each.


Enrollment Information
If you are interested in enrolling in this trial, please contact:
Name – Franziska Hoche
Email – fhoche@partners.org
Phone – 617-726-3669
Institution  –  MGH - Massachusetts General Hospital, Boston, MA
Principal Investigator  – Jeremy D Schmahmann, MD
  
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name  – Franziska Hoche, MD
Email  – fhoche@partners.org
Phone  – 6177263669